Innovation1 Biotech Inc. (IVBT)

USD 0.0

(0.0%)

Long Term Debt Summary of Innovation1 Biotech Inc.

  • Innovation1 Biotech Inc.'s latest annual long term debt in 2023 was 218.99 Thousand USD , down -26.61% from previous year.
  • Innovation1 Biotech Inc.'s latest quarterly long term debt in 2023 FY was 218.99 Thousand USD , down -26.61% from previous quarter.
  • Innovation1 Biotech Inc. reported annual long term debt of 298.42 Thousand USD in 2022, down 0.0% from previous year.
  • Innovation1 Biotech Inc. reported annual long term debt of - USD in 2021, down 0.0% from previous year.
  • Innovation1 Biotech Inc. reported quarterly long term debt of 218.99 Thousand USD for 2023 FY, down -26.61% from previous quarter.
  • Innovation1 Biotech Inc. reported quarterly long term debt of 218.99 Thousand USD for 2023 Q4, up 97.62% from previous quarter.

Annual Long Term Debt Chart of Innovation1 Biotech Inc. (2023 - 2015)

Historical Annual Long Term Debt of Innovation1 Biotech Inc. (2023 - 2015)

Year Long Term Debt Long Term Debt Growth
2023 218.99 Thousand USD -26.61%
2022 298.42 Thousand USD 0.0%
2021 - USD 0.0%
2020 - USD 0.0%
2019 - USD 0.0%
2018 - USD 0.0%
2017 - USD 0.0%
2016 - USD 0.0%
2015 - USD 0.0%

Peer Long Term Debt Comparison of Innovation1 Biotech Inc.

Name Long Term Debt Long Term Debt Difference
America Great Health 1.12 Million USD 80.501%
Gene Biotherapeutics, Inc. - USD -Infinity%
Evolutionary Genomics, Inc. 3.74 Million USD 94.15%
Point of Care Nano-Technology, Inc. - USD -Infinity%
Vicapsys Life Sciences, Inc. - USD -Infinity%